![Patrick P. Lally](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patrick P. Lally
Direktor/Vorstandsmitglied bei CorneaGen, Inc.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Brent Furse | M | 55 |
Vero Biotech, Inc.
| - |
Bernie Iliakis | M | - |
CorneaGen, Inc.
![]() CorneaGen, Inc. Medical SpecialtiesHealth Technology CorneaGen, Inc. engages in the provision of cornea care services. It offers precision cut corneal tissue, Descemet’s Membrane Endothelial Keratoplasty, and Descemet’s Stripping Automated Endothelial Keratoplasty. The firm's products include EndoSerter, Geuder Glass Cannula, and Donor Trephine Punch. The company was founded in 2016 and is headquartered in Seattle, WA. | 8 Jahre |
Tadd Seaton Wessel | M | - |
Petrichor Healthcare Capital Management LP
![]() Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | 8 Jahre |
David Katona | M | - |
Petrichor Healthcare Capital Management LP
![]() Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | 3 Jahre |
Baabur M S Khondker | M | - |
Petrichor Healthcare Capital Management LP
![]() Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | 4 Jahre |
Michael H. Goldstein | M | 57 |
Aurion Biotech, Inc.
![]() Aurion Biotech, Inc. Medical/Nursing ServicesHealth Services Aurion Biotech, Inc. is a clinical-stage biotech company with offices in multiple locations. Aurion Biotech has initiated clinical trials in the US in 2023. The company is based in Seattle, WA. The company's mission is to restore vision to millions of patients with life-changing regenerative therapies. Aurion Biotech has received the prestigious Prix Galien award for best start-up in biotech. The company's first candidate is an off-the-shelf, clinically validated cell therapy for corneal care, which has received regulatory approval. The company is privately held and backed by leading investors, including Deerfield, Alcon, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures. Greg Kunst has been the CEO of the company since 2021. | 2 Jahre |
Richard Lindstrom | M | 76 |
CorneaGen, Inc.
![]() CorneaGen, Inc. Medical SpecialtiesHealth Technology CorneaGen, Inc. engages in the provision of cornea care services. It offers precision cut corneal tissue, Descemet’s Membrane Endothelial Keratoplasty, and Descemet’s Stripping Automated Endothelial Keratoplasty. The firm's products include EndoSerter, Geuder Glass Cannula, and Donor Trephine Punch. The company was founded in 2016 and is headquartered in Seattle, WA.
Aurion Biotech, Inc.
![]() Aurion Biotech, Inc. Medical/Nursing ServicesHealth Services Aurion Biotech, Inc. is a clinical-stage biotech company with offices in multiple locations. Aurion Biotech has initiated clinical trials in the US in 2023. The company is based in Seattle, WA. The company's mission is to restore vision to millions of patients with life-changing regenerative therapies. Aurion Biotech has received the prestigious Prix Galien award for best start-up in biotech. The company's first candidate is an off-the-shelf, clinically validated cell therapy for corneal care, which has received regulatory approval. The company is privately held and backed by leading investors, including Deerfield, Alcon, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures. Greg Kunst has been the CEO of the company since 2021. | - |
Greg Kunst | M | - |
Aurion Biotech, Inc.
![]() Aurion Biotech, Inc. Medical/Nursing ServicesHealth Services Aurion Biotech, Inc. is a clinical-stage biotech company with offices in multiple locations. Aurion Biotech has initiated clinical trials in the US in 2023. The company is based in Seattle, WA. The company's mission is to restore vision to millions of patients with life-changing regenerative therapies. Aurion Biotech has received the prestigious Prix Galien award for best start-up in biotech. The company's first candidate is an off-the-shelf, clinically validated cell therapy for corneal care, which has received regulatory approval. The company is privately held and backed by leading investors, including Deerfield, Alcon, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures. Greg Kunst has been the CEO of the company since 2021. | 3 Jahre |
Thomas Frinzi | M | 68 |
Aurion Biotech, Inc.
![]() Aurion Biotech, Inc. Medical/Nursing ServicesHealth Services Aurion Biotech, Inc. is a clinical-stage biotech company with offices in multiple locations. Aurion Biotech has initiated clinical trials in the US in 2023. The company is based in Seattle, WA. The company's mission is to restore vision to millions of patients with life-changing regenerative therapies. Aurion Biotech has received the prestigious Prix Galien award for best start-up in biotech. The company's first candidate is an off-the-shelf, clinically validated cell therapy for corneal care, which has received regulatory approval. The company is privately held and backed by leading investors, including Deerfield, Alcon, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures. Greg Kunst has been the CEO of the company since 2021.
CorneaGen, Inc.
![]() CorneaGen, Inc. Medical SpecialtiesHealth Technology CorneaGen, Inc. engages in the provision of cornea care services. It offers precision cut corneal tissue, Descemet’s Membrane Endothelial Keratoplasty, and Descemet’s Stripping Automated Endothelial Keratoplasty. The firm's products include EndoSerter, Geuder Glass Cannula, and Donor Trephine Punch. The company was founded in 2016 and is headquartered in Seattle, WA. | 4 Jahre |
Donald Berwick | M | 77 |
Petrichor Healthcare Capital Management LP
![]() Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | - |
Todd Brady | M | 45 |
Vero Biotech, Inc.
| - |
Peter Greenleaf | M | 54 |
Petrichor Healthcare Capital Management LP
![]() Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | - |
Andrew ElBardissi | M | 42 |
Aurion Biotech, Inc.
![]() Aurion Biotech, Inc. Medical/Nursing ServicesHealth Services Aurion Biotech, Inc. is a clinical-stage biotech company with offices in multiple locations. Aurion Biotech has initiated clinical trials in the US in 2023. The company is based in Seattle, WA. The company's mission is to restore vision to millions of patients with life-changing regenerative therapies. Aurion Biotech has received the prestigious Prix Galien award for best start-up in biotech. The company's first candidate is an off-the-shelf, clinically validated cell therapy for corneal care, which has received regulatory approval. The company is privately held and backed by leading investors, including Deerfield, Alcon, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures. Greg Kunst has been the CEO of the company since 2021. | - |
Michael Beecham | M | - |
Petrichor Healthcare Capital Management LP
![]() Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | 7 Jahre |
Hayden Fownes | M | - |
Petrichor Healthcare Capital Management LP
![]() Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | - |
Daniel Salazar | M | - |
Vero Biotech, Inc.
| - |
Raymond Schinazi | M | 74 |
Petrichor Healthcare Capital Management LP
![]() Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | - |
Robert Stevens | M | - |
CorneaGen, Inc.
![]() CorneaGen, Inc. Medical SpecialtiesHealth Technology CorneaGen, Inc. engages in the provision of cornea care services. It offers precision cut corneal tissue, Descemet’s Membrane Endothelial Keratoplasty, and Descemet’s Stripping Automated Endothelial Keratoplasty. The firm's products include EndoSerter, Geuder Glass Cannula, and Donor Trephine Punch. The company was founded in 2016 and is headquartered in Seattle, WA. | - |
Bill Link | M | 78 |
Aurion Biotech, Inc.
![]() Aurion Biotech, Inc. Medical/Nursing ServicesHealth Services Aurion Biotech, Inc. is a clinical-stage biotech company with offices in multiple locations. Aurion Biotech has initiated clinical trials in the US in 2023. The company is based in Seattle, WA. The company's mission is to restore vision to millions of patients with life-changing regenerative therapies. Aurion Biotech has received the prestigious Prix Galien award for best start-up in biotech. The company's first candidate is an off-the-shelf, clinically validated cell therapy for corneal care, which has received regulatory approval. The company is privately held and backed by leading investors, including Deerfield, Alcon, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures. Greg Kunst has been the CEO of the company since 2021. | - |
Sir Bruce E. Keogh | M | - |
Petrichor Healthcare Capital Management LP
![]() Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | 3 Jahre |
Christine Z. McCauley | F | 59 |
Aurion Biotech, Inc.
![]() Aurion Biotech, Inc. Medical/Nursing ServicesHealth Services Aurion Biotech, Inc. is a clinical-stage biotech company with offices in multiple locations. Aurion Biotech has initiated clinical trials in the US in 2023. The company is based in Seattle, WA. The company's mission is to restore vision to millions of patients with life-changing regenerative therapies. Aurion Biotech has received the prestigious Prix Galien award for best start-up in biotech. The company's first candidate is an off-the-shelf, clinically validated cell therapy for corneal care, which has received regulatory approval. The company is privately held and backed by leading investors, including Deerfield, Alcon, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures. Greg Kunst has been the CEO of the company since 2021. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 21 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Patrick P. Lally
- Persönliches Netzwerk